Isabelle Boileau - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Di Ciano P, de Wit H, Mansouri E, Houle S, Boileau I, Le Foll B. The influence of conditioned stimuli on [C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence. Scientific Reports. 11: 11667. PMID 34083612 DOI: 10.1038/s41598-021-90915-y  0.383
2021 Kish SJ, O'Leary G, Mamelak M, McCluskey T, Warsh JJ, Shapiro C, Bies R, Yu Y, Pollock B, Tong J, Boileau I. Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study. Human Psychopharmacology. e2791. PMID 33899252 DOI: 10.1002/hup.2791  0.466
2019 Mansouri E, Nobrega JN, Hill MN, Tyndale RF, Lee FS, Hendershot CS, Best LM, Di Ciano P, Balsevich G, Sloan ME, Kish SJ, Tong J, Le Foll B, Boileau I. D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31775159 DOI: 10.1038/S41386-019-0580-8  0.333
2019 Mansouri E, Tyndale RF, Hendershot CS, Best LM, Di Ciano P, Hill M, Nobrega JJ, Sloan M, Kish S, Tong J, Le Foll B, Boileau I. S203. Fatty Acid Amide Hydrolase Polymorphism C385A Associated With Dopamine D2/3 Receptor Levels: A PET Study With [11C]-(+)-PHNO Biological Psychiatry. 85: S376. DOI: 10.1016/J.Biopsych.2019.03.954  0.316
2018 Di Ciano P, Mansouri E, Tong J, Wilson AA, Houle S, Boileau I, Duvauchelle T, Robert P, Schwartz JC, Le Foll B. Occupancy of dopamine D and D receptors by a novel D3 partial agonist BP1.4979: a [C]-(+)-PHNO PET study in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30659274 DOI: 10.1038/s41386-018-0285-4  0.362
2018 Clark L, Boileau I, Zack M. Neuroimaging of reward mechanisms in Gambling disorder: an integrative review. Molecular Psychiatry. PMID 30214041 DOI: 10.1038/s41380-018-0230-2  0.389
2017 Malik S, Jacobs M, Cho SS, Boileau I, Blumberger D, Heilig M, Wilson A, Daskalakis ZJ, Strafella AP, Zangen A, Le Foll B. Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [(11)C] PHNO-PET pilot trial in healthy humans. Brain Imaging and Behavior. PMID 29170944 DOI: 10.1007/S11682-017-9800-1  0.429
2017 Caravaggio F, Ku Chung J, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, Chakravarty MM, Remington G, Graff-Guerrero A. The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET. Human Brain Mapping. PMID 28752565 DOI: 10.1002/Hbm.23744  0.444
2017 Thiruchselvam T, Wilson AA, Boileau I, Le Foll B. A preliminary investigation of the effect of acute alcohol on dopamine transmission as assessed by [(11) C]-(+)-PHNO. Alcoholism, Clinical and Experimental Research. PMID 28421623 DOI: 10.1111/acer.13403  0.418
2017 Jaworska N, Cox SM, Casey KF, Boileau I, Cherkasova M, Larcher K, Dagher A, Benkelfat C, Leyton M. Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness? Plos One. 12: e0174219. PMID 28346539 DOI: 10.1371/Journal.Pone.0174219  0.705
2017 Le Foll B, Thiruchselvam T, Lu SX, Mohammed S, Mansouri E, Lagzdins D, Nakajima S, Wilson AA, Graff-Guerrero A, Di Ciano P, Boileau I. Investigating the effects of norepinephrine α1 receptor blockade on dopamine levels: A pilot PET study with [(11) C]-(+)-PHNO in controls. Synapse (New York, N.Y.). PMID 28233334 DOI: 10.1002/Syn.21968  0.453
2016 Payer D, Williams B, Mansouri E, Stevanovski S, Nakajima S, Le Foll B, Kish S, Houle S, Mizrahi R, George SR, George TP, Boileau I. Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology. 76: 192-196. PMID 27951520 DOI: 10.1016/J.Psyneuen.2016.11.034  0.575
2016 Kish SJ, Boileau I, Callaghan RC, Tong J. Brain dopamine neurone "damage": methamphetamine users vs. parkinson's disease ─ A critical assessment of the evidence. The European Journal of Neuroscience. PMID 27519465 DOI: 10.1111/Ejn.13363  0.414
2016 Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/Npp.2016.108  0.525
2016 Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I, Baker GB, Diksic M, Soucy JP, Pruessner JC, Cawley-Fiset E, Casey KF, Benkelfat C. Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers. Translational Psychiatry. 6: e740. PMID 26905412 DOI: 10.1038/tp.2016.6  0.487
2015 Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. PMID 26718579 DOI: 10.1212/Wnl.0000000000002285  0.336
2015 Di Ciano P, Guranda M, Lagzdins D, Tyndale RF, Gamaleddin I, Selby P, Boileau I, Le Foll B. Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26442600 DOI: 10.1038/Npp.2015.305  0.414
2015 Di Ciano P, Pushparaj A, Kim A, Hatch J, Masood T, Ramzi A, Khaled MA, Boileau I, Winstanley CA, Le Foll B. The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task. Plos One. 10: e0136267. PMID 26352802 DOI: 10.1371/journal.pone.0136267  0.332
2015 Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ. Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26321315 DOI: 10.1038/Npp.2015.267  0.429
2015 Boileau I, Nakajima S, Payer D. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26141509 DOI: 10.1016/J.Euroneuro.2015.06.002  0.448
2015 Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH, Graff-Guerrero A, Boileau I. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [(11)C]-(+)-PHNO PET Study in Humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26089182 DOI: 10.1038/Npp.2015.177  0.451
2015 Nakajima S, Caravaggio F, Boileau I, Chung JK, Plitman E, Gerretsen P, Wilson AA, Houle S, Mamo DC, Graff-Guerrero A. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26058690 DOI: 10.1038/Jcbfm.2015.129  0.324
2015 Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/Mds.26135  0.427
2015 Wing VC, Payer DE, Houle S, George TP, Boileau I. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1417-27. PMID 25502631 DOI: 10.1038/Npp.2014.327  0.386
2014 Le Foll B, Collo G, Rabiner EA, Boileau I, Merlo Pich E, Sokoloff P. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. Progress in Brain Research. 211: 255-75. PMID 24968784 DOI: 10.1016/B978-0-444-63425-2.00011-8  0.417
2014 Mizrahi R, Kenk M, Suridjan I, Boileau I, George TP, McKenzie K, Wilson AA, Houle S, Rusjan P. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1479-89. PMID 24385130 DOI: 10.1038/Npp.2013.347  0.493
2014 Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/Mp.2013.163  0.574
2014 Payer D, Balasubramaniam G, Boileau I. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 4-8. PMID 23999545 DOI: 10.1016/J.Pnpbp.2013.08.012  0.371
2014 Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC, Zawertailo L, Busto U, Selby P, Brody AL, George TP, Boileau I. Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 415-24. PMID 23954846 DOI: 10.1038/Npp.2013.209  0.357
2014 Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 311-8. PMID 23921256 DOI: 10.1038/Npp.2013.192  0.335
2013 Chiuccariello L, Boileau I, Guranda M, Rusjan PM, Wilson AA, Zawertailo L, Houle S, Busto U, Le Foll B. Presentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: A [11C]-(+)-PHNO PET study. Plos One. 8: e60382. PMID 23555962 DOI: 10.1371/Journal.Pone.0060382  0.394
2013 Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/Add.12066  0.45
2012 Suridjan I, Boileau I, Bagby M, Rusjan PM, Wilson AA, Houle S, Mizrahi R. Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits. Journal of Psychiatric Research. 46: 890-7. PMID 22475321 DOI: 10.1016/j.jpsychires.2012.03.009  0.477
2012 Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/Jneurosci.4371-11.2012  0.44
2012 Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, Remington G, Houle S, Wilson AA. Increased stress-induced dopamine release in psychosis. Biological Psychiatry. 71: 561-7. PMID 22133268 DOI: 10.1016/J.Biopsych.2011.10.009  0.51
2010 Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (New York, N.Y.). 64: 417-20. PMID 20169578 DOI: 10.1002/Syn.20743  0.388
2010 Boileau I, Guttman M, Adams JR, Houle S, Tong J, Rusjan P, Wilson A, Kapur S, Kish SJ. Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride Neuroimage. 52: S84. DOI: 10.1016/J.Neuroimage.2010.04.067  0.373
2009 Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/Brain/Awn337  0.404
2008 Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9850-6. PMID 18815269 DOI: 10.1523/Jneurosci.3008-08.2008  0.465
2008 Tong J, Wilson AA, Boileau I, Houle S, Kish SJ. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (New York, N.Y.). 62: 873-6. PMID 18720517 DOI: 10.1002/Syn.20573  0.513
2008 Soliman A, O'Driscoll GA, Pruessner J, Holahan AL, Boileau I, Gagnon D, Dagher A. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2033-41. PMID 17957215 DOI: 10.1038/Sj.Npp.1301597  0.668
2007 Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, Benkelfat C. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3998-4003. PMID 17428975 DOI: 10.1523/Jneurosci.4370-06.2007  0.739
2006 Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Archives of General Psychiatry. 63: 1386-95. PMID 17146013 DOI: 10.1001/Archpsyc.63.12.1386  0.719
2006 Boileau I, Dagher A, Welfeld K, Leyton M, Booij L, Sibon I, Diksic M, Benkelfat C. Drug-associated context increases dopamine release during placebo administration: A PET [11C]raclopride study in healthy volunteers Neuroimage. 31: T112. DOI: 10.1016/J.Neuroimage.2006.04.098  0.671
2004 Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse (New York, N.Y.). 54: 65-71. PMID 15352131 DOI: 10.1002/Syn.20066  0.635
2004 Zald DH, Boileau I, El-Dearedy W, Gunn R, McGlone F, Dichter GS, Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4105-12. PMID 15115805 DOI: 10.1523/Jneurosci.4643-03.2004  0.539
2004 Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 427-32. PMID 14583741 DOI: 10.1038/Sj.Npp.1300328  0.739
2003 Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse (New York, N.Y.). 49: 226-31. PMID 12827641 DOI: 10.1002/Syn.10226  0.682
2003 Boileau I, Dagher A, Benkelfat C. Increased amphetamine-induced dopamine release during experimental sensitization to psychostimulants: A PET/11C-raclopride study in healthy volunteers Schizophrenia Research. 60: 238-239. DOI: 10.1016/S0920-9964(03)81238-0  0.527
2002 Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 1027-35. PMID 12464459 DOI: 10.1016/S0893-133X(02)00366-4  0.714
Show low-probability matches.